跳至主要内容
临床试验/NCT00433316
NCT00433316已完成3 期

Pain Relief by Continuous Intra-Peritoneal Nebulization of Ropivacaine During Gynecological Laparoscopic Surgery

Carmel Medical Center1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2007年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
VAS score

研究概览

简要总结

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecological laparoscopic surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Elective gynecologic laparoscopic surgery including unilateral or bilateral salpingo-oopherectomy or ovarian cystectomy.
  • The patient is not participating in other medical study at present or in the last 30 days.
  • The patient signed on an informed consent.
  • Age 18 years and above.
  • ASA (American Society of Anesthesiologists) physical status grade 1- 2.

排除标准

  • Allergy to Ropivacaine, other local anesthetics or other medications listed in the protocol.
  • The patient is participating in other medical experiment at present or in the last 30 days.
  • Acute Pelvic Inflammatory Disease.
  • Coumadin or Aspirin treatment.
  • ASA physical status grade 3-
  • Age < 18 years.
  • Significant arrythmias
  • Analgesic treatment for chronic pain

研究组 & 干预措施

study

Experimental

Receiving 10ml of 1% ropivacaine

干预措施: ropivacaine (Drug)

Control

Placebo Comparator

Receiving 10ml of saline

干预措施: Aeroneb Pro Nezulizer, Aerogen, Ireland (Device)

结局指标

主要结局

VAS score

时间窗: early post-operative

次要结局

未报告次要终点

研究者

发起方
Carmel Medical Center
申办方类型
Other

研究点 (1)

Loading locations...

相似试验